Rosoxacin in the treatment of uncomplicated gonorrhoea in men.

K Panikabutra, C Ariyarit, A Chitwarakorn, C Saensanoh
{"title":"Rosoxacin in the treatment of uncomplicated gonorrhoea in men.","authors":"K Panikabutra,&nbsp;C Ariyarit,&nbsp;A Chitwarakorn,&nbsp;C Saensanoh","doi":"10.1136/sti.60.4.231","DOIUrl":null,"url":null,"abstract":"<p><p>Between 3 January and 4 March 1983 we treated 200 male patients diagnosed as having uncomplicated gonococcal urethritis with one of two regimens. They were divided into two groups and randomly assigned to treatment with either 2 g spectinomycin administered intramuscularly (group A) or 300 mg rosoxacin by mouth (group B). Of 187 isolates tested for the production of beta-lactamase, 101 (54%) were penicillinase producing Neisseria gonorrhoeae (PPNG) strains. All 81 cases followed in group A (spectinomycin) were cured, compared with 88.5% (77 out of 87) of the patients followed in group B (rosoxacin). We concluded that rosoxacin at a dosage of 300 mg administered orally was fairly effective in the treatment of gonococcal urethritis in men caused by both PPNG and non-PPNG strains.</p>","PeriodicalId":22309,"journal":{"name":"The British Journal of Venereal Diseases","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"1984-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1136/sti.60.4.231","citationCount":"8","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The British Journal of Venereal Diseases","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/sti.60.4.231","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 8

Abstract

Between 3 January and 4 March 1983 we treated 200 male patients diagnosed as having uncomplicated gonococcal urethritis with one of two regimens. They were divided into two groups and randomly assigned to treatment with either 2 g spectinomycin administered intramuscularly (group A) or 300 mg rosoxacin by mouth (group B). Of 187 isolates tested for the production of beta-lactamase, 101 (54%) were penicillinase producing Neisseria gonorrhoeae (PPNG) strains. All 81 cases followed in group A (spectinomycin) were cured, compared with 88.5% (77 out of 87) of the patients followed in group B (rosoxacin). We concluded that rosoxacin at a dosage of 300 mg administered orally was fairly effective in the treatment of gonococcal urethritis in men caused by both PPNG and non-PPNG strains.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
红沙星治疗男性无并发症淋病的疗效观察。
在1983年1月3日至3月4日期间,我们用两种方案中的一种治疗了200名确诊为无并发症淋球菌性尿道炎的男性患者。他们被分为两组,随机分配给肌肉注射2g大观霉素(A组)或口服300 mg罗沙星(B组)。在187株产生β -内酰胺酶的分离株中,101株(54%)是产生青霉素酶的淋病奈瑟菌(PPNG)菌株。A组(大观霉素)随访81例患者全部治愈,而B组(红沙星)随访87例患者中有77例(88.5%)治愈。我们得出结论,口服300毫克罗沙星对于治疗由PPNG和非PPNG菌株引起的男性淋球菌性尿道炎相当有效。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Demonstration by electron microscopy of pili on Gardnerella vaginalis. Susceptibility to antimicrobials of Neisseria gonorrhoeae isolated in Singapore: implications on the need for more effective treatment regimens and control strategies. Attachment of Treponema pallidum to fibronectin, laminin, collagen IV, and collagen I, and blockage of attachment by immune rabbit IgG. Treponema pallidum specific IgM haemagglutination test for serodiagnosis of syphilis. Histological, immunofluorescent, and ultrastructural features of lymphogranuloma venereum: a case report.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1